Efficacy and safety of febuxostat in the treatment of hyperuricemia in stable kidney transplant recipients
Tadashi Sofue,1 Masashi Inui,2 Taiga Hara,1 Yoko Nishijima,1 Kumiko Moriwaki,1 Yushi Hayashida,3 Nobufumi Ueda,3 Akira Nishiyama,4 Yoshiyuki Kakehi,3 Masakazu Kohno1 1Division of Nephrology and Dialysis, Department of Cardiorenal and Cerebrovascular Medicine, Kagawa University, Kagawa, 2Department...
Main Authors: | Sofue T, Inui M, Hara T, Nishijima Y, Moriwaki K, Hayashida Y, Ueda N, Nishiyama A, Kakehi Y, Kohno M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-02-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/efficacy-and-safety-of-febuxostat-in-the-treatment-of-hyperuricemia-in-peer-reviewed-article-DDDT |
Similar Items
-
Switching from allopurinol to febuxostat: efficacy and safety in the treatment of hyperuricemia in renal transplant recipients
by: Yanchun Li, et al.
Published: (2019-01-01) -
Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease
by: Tetsu Akimoto, et al.
Published: (2014-01-01) -
Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease
by: Tetsu Akimoto, et al.
Published: (2014-08-01) -
Management of hyperuricemia in gout: focus on febuxostat
by: Mattheus K Reinders, et al.
Published: (2010-01-01) -
FEBUXOSTAT FOR TREATMENT OF CHRONIC HYPERURICEMIA IN GOUT PATIENTS
by: M. S. Petrova, et al.
Published: (2017-11-01)